Cargando…

1428. Increased Consumption of Pivmecillinam in Primary Care for Uncomplicated Urinary Tract Infection (uUTI) Is Not Associated With Increased Resistance Rates

BACKGROUND: The evolution of antibiotic resistance in Escherichia coli (E. coli) hampers the treatment of UTIs, mirroring the global public health concerns around antimicrobial resistance. Pivmecillinam, an oral prodrug of mecillinam (a β-lactam antibiotic), is used as first-line treatment for uUTIs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsen, Anders Rhod, Henriksen, Anne Santerre, Frimodt-Møller, Niels
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644580/ http://dx.doi.org/10.1093/ofid/ofab466.1620

Ejemplares similares

1433. Impact of 2019 US Food and Drug Administration (FDA) Guidance on Developing Drugs for Urinary Tract Infection (UTI) on the Perceived Efficacy of Antibiotics for the Treatment of Uncomplicated UTI (uUTI)
por: Henriksen, Anne Santerre, et al.
Publicado: (2021)

622. Population Pharmacokinetic Analysis and Probability of Target Attainment Simulations of Pivmecillinam for the Treatment of Uncomplicated Urinary Tract Infection
por: Santerre Henriksen, Anne Laurence, et al.
Publicado: (2022)

1453. Cephalexin and Cefadroxil Are Not Therapeutic Equivalents for Uncomplicated Cystitis (uUTI): Further Analysis of Cefazolin Surrogate Susceptibility Testing Criteria
por: Jones, Ronald N, et al.
Publicado: (2019)

Pivmecillinam for Uncomplicated Lower Urinary Tract Infections Caused by Staphylococcus saprophyticus—Cumulative Observational Data from Four Recent Clinical Studies
por: Jansåker, Filip, et al.
Publicado: (2019)

Three versus five days of pivmecillinam for community-acquired uncomplicated lower urinary tract infection: A randomised, double-blind, placebo-controlled superiority trial()
por: Jansåker, Filip, et al.
Publicado: (2019)

LB-1. Efficacy and Safety of Oral Sulopenem Etzadroxil/Probenecid Versus Oral Ciprofloxacin in the Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women: Results from the SURE-1 Trial
por: Dunne, Michael W, et al.
Publicado: (2020)

US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales
por: Lodise, Thomas P, et al.
Publicado: (2021)

The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections – a randomized, double-blinded, placebo-controlled clinical trial study protocol
por: Jansåker, Filip, et al.
Publicado: (2016)

Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study
por: Jansåker, Filip, et al.
Publicado: (2019)

Escherichia coli resistance, treatment patterns and clinical outcomes among females with uUTI in Germany: a retrospective physician-based chart review study
por: Naber, Kurt G., et al.
Publicado: (2023)

Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women—A double-blind, randomized non-inferiority trial
por: Vik, Ingvild, et al.
Publicado: (2018)

Recurrent Urinary Tract Infections: Unraveling the Complicated Environment of Uncomplicated rUTIs
por: Josephs-Spaulding, Jonathan, et al.
Publicado: (2021)

1043. Activity of Mecillinam Against Enterobacterales Isolates Collected From Patients With Urinary Tract Infections (UTIs) in the USA During 2019
por: Hawser, Stephen, et al.
Publicado: (2021)

Retrospective study of men with E. coli UTI treated with an oral antibiotic, and risk for a new prescription or hospital admission due to UTI
por: Jansåker, Filip, et al.
Publicado: (2020)

Mutational change of CTX‐M‐15 to CTX‐M‐127 resulting in mecillinam resistant Escherichia coli during pivmecillinam treatment of a patient
por: Nielsen, Karen Leth, et al.
Publicado: (2019)

Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men
por: Montelin, Hanna, et al.
Publicado: (2019)

Retracted: In vivo mecillinam resistance in Escherichia coli after pivmecillinam treatment of a urinary tract infection
Publicado: (2019)

Treatment of uncomplicated UTI in males: a systematic review of the literature
por: Farrell, Karen, et al.
Publicado: (2021)

COSUTI: A Core Outcome Set (COS) for Interventions for the Treatment of Uncomplicated Urinary Tract Infection (UTI) in Adults
por: Beecher, Claire, et al.
Publicado: (2022)

Effect of point-of-care susceptibility testing in general practice on appropriate prescription of antibiotics for patients with uncomplicated urinary tract infection: a diagnostic randomised controlled trial
por: Holm, Anne, et al.
Publicado: (2017)

1475. Understanding Prescribing Practices for Uncomplicated Urinary Tract Infections (UTIs) in the Primary Care Setting: A Pilot Study
por: Pinkerton, Mark, et al.
Publicado: (2019)

1425. Revisiting β-Lactams for Treatment of Uncomplicated Urinary Tract Infections: Evaluation of Twice-daily Cephalexin for Empiric Treatment of UTIs
por: Benning, Molly, et al.
Publicado: (2021)

The Risk of Pyelonephritis Following Uncomplicated Cystitis: A Nationwide Primary Healthcare Study
por: Jansåker, Filip, et al.
Publicado: (2022)

COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults
por: Duane, Sinead, et al.
Publicado: (2019)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
por: Batra, Priyam, et al.
Publicado: (2020)

Pivmecillinam with Amoxicillin/Clavulanic acid as step down oral therapy in febrile Urinary Tract Infections caused by ESBL-producing Enterobacterales (PACUTI)
por: Tverring, Jonas, et al.
Publicado: (2023)

1428. The proportion of excess hospital-onset antibiotic-resistant infections attributable to patients diagnosed with COVID-19 in U.S. hospitals, 2019-2021
por: Wolford, Hannah, et al.
Publicado: (2023)

2222. 3-Day Ceftriaxone vs. Longer Durations of Therapy For Inpatient Treatment of Uncomplicated UTI 
por: Elajouz, Balsam, et al.
Publicado: (2022)

Acute Uncomplicated UTI and E. coli Resistance: Implications for First-Line Empirical Antibiotic Therapy
por: Perfetto, Eleanor M,, et al.
Publicado: (2004)

The Increasing Value of Modern Sanatorium Treatment as Judged by the After-Histories of the Patients
por: Frimodt-Möller, C.
Publicado: (1937)

2824. 3rd Generation Cephalosporin (3rd CEP) Use and Antibiotic Selection Appropriateness for Uncomplicated Febrile Urinary Tract Infections (UTI) in Children
por: Dantas, Marina, et al.
Publicado: (2023)

Frailty associated urinary tract infections (FaUTIs)
por: Kostakopoulos, Nikolaos A., et al.
Publicado: (2021)

Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland
por: O’Kelly, Fardod, et al.
Publicado: (2016)

1428. Comparing Outcomes of Diabetic Foot Infections Requiring Amputation, Negative vs. Positive Margins
por: Dixon, Michael K, et al.
Publicado: (2019)

1428. Clinical Characteristics and Management of Nontuberculous Mycobacterial Infections in the Finger Lakes Region of New York
por: Croix, Michael, et al.
Publicado: (2022)

The efficacy of pivmecillinam in oral step-down treatment in hospitalised patients with E. coli bacteremic urinary tract infection; a single-arm, uncontrolled treatment study
por: Hansen, Bjørn Åsheim, et al.
Publicado: (2022)

2238. Estimating the impact of antibiotic exposure on antibiotic resistance in uncomplicated UTI using machine learning causal inference
por: Kanjilal, Sanjat, et al.
Publicado: (2022)

INSIG-2 promoter polymorphism and obesity related phenotypes: association study in 1428 members of 248 families
por: Hall, Darroch H, et al.
Publicado: (2006)

Urinary tract infection (UTI) and infection control in municipal nursing homes
por: Andersen, A-M, et al.
Publicado: (2011)

The role of toll-like receptors (TLRs) in urinary tract infections (UTIs)
por: Behzadi, Elham, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6vpeeqe4evtecr5ftqsqdl10ju